H&T Presspart partners with Hovione to commercialize PowdAir Plus inhaler

H&T Presspart entered a collaborative partnership with Hovione Technology, purchasing global rights to manufacture and commercialize Hovione's capsule-based dry powder inhaler, renamed PowdAir Plus, to expand its respiratory care portfolio.

“This is a strategically significant partnership and underlines our commitment to forging alliances that accelerate the development, global scale-up and commercialisation of novel drug delivery solutions for respiratory patients.”medicaldevice-network.com

• 1 source
• medicaldevice-network.comH&T enters strategic alliance with Hovione to expand respiratory care portfolio - Medical Device NetworkadminMay 1, 2017

Summarized from public sources; check the original articles before acting on it.